Related references
Note: Only part of the references are listed.Candidate Reference Measurement Procedure for the Quantification of Total Serum Cortisol with LC-MS/MS
James M. Hawley et al.
CLINICAL CHEMISTRY (2016)
HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels
Wijtske Annema et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association
Akihiro Shimada et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?
G. Kees Hovingh et al.
CIRCULATION (2015)
Metabolic comorbidities in Cushing's syndrome
Francesco Ferrau et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Plasma Cholesteryl Ester Transfer Protein Is Predominantly Derived From Kupffer Cells
Yanan Wang et al.
HEPATOLOGY (2015)
Stress, the Stress System and the Role of Glucocorticoids
Nicolas C. Nicolaides et al.
NEUROIMMUNOMODULATION (2015)
The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency - Results from a randomized controlled trial
Jorien Werumeus Buning et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects
Robin P. F. Dullaart et al.
CLINICAL BIOCHEMISTRY (2014)
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
Daniel Keene et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
Olaf M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
Thomas Gautier et al.
JOURNAL OF LIPID RESEARCH (2013)
Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis
Ivan Ferraz-Amaro et al.
JOURNAL OF RHEUMATOLOGY (2013)
The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature
Zhenyu Qin
ATHEROSCLEROSIS (2012)
Adverse Cardiovascular Outcomes of Corticosteroid Excess
Eduardo Pimenta et al.
ENDOCRINOLOGY (2012)
High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: A nested case control study
Paul J. W. H. Kappelle et al.
ATHEROSCLEROSIS (2011)
HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment
Robin P. F. Dullaart et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
Willeke de Haan et al.
ATHEROSCLEROSIS (2008)
Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the-629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients
Robin P. F. Dullaart et al.
CLINICAL ENDOCRINOLOGY (2008)
The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins
R. P. F. DULLAART et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Beyond high-density lipoprotein cholesterol levels - Evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
Emil M. deGoma et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Common variation in the CETP gene and the implications for cardiovascular disease and its treatment:: an updated analysis
Robin P. F. Dullaart et al.
PHARMACOGENOMICS (2008)
Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins
Geesje M. Dallinga-Thie et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients
Helena Filipsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: Role of CETP and triglycerides
R de Vries et al.
DIABETES (2005)
The effect of cholesteryl ester transfer protein-629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides
SE Borggreve et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Diagnosis and complications of Cushing's syndrome: A consensus statement
G Arnaldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men:: role in altered high density lipoproteins
JAM Beentjes et al.
ATHEROSCLEROSIS (2000)
Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy
JAM Beentjes et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2000)